Philip Huxley
Chief Executive Officer at Ducentis BioTherapeutics Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Rebecca Ashfield | M | 57 |
Ducentis BioTherapeutics Ltd.
 Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | 10 years |
| David John Blackbourn | M | - |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | 10 years |
| Philippe Lenoble | M | 53 |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | - |
| Andrea Giacomo Mica | M | 56 |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | - |
| Clare Elizabeth Terlouw | F | 51 |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | - |
| Alan Watt | M | - |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Philip Huxley
- Personal Network
